FCGR2A and COVID-19: Among the COVID-19 acute patients’ sera, FcγR-mediated ADE activity was found in 1 (number 60), 1 (number 85), and 2 (numbers 97 and 111) samples from the patients with mild (n = 8), moderate (n = 13), and severe (n = 8) symptoms, respectively.